WANG Fei, HUANG Haitao, SHEN Liang, LU Chenxi, ZHONG Chongjun. Effect of ulinastatin on inflammatory cytokines and cardiopulmonary function in hypoxemia patients after off-pump CABG[J]. Surgical Research and New Technique, 2018, 7(3): 153-156.
[1] 徐枫,梅运清.冠状动脉旁路移植术后并发症危险因素研究进展[J].外科研究与新技术, 2013,2(4):267-271. [2] 陶广华,张随随,朱玲钰,等.乌司他丁的药理作用机制及临床应用进展[J].中国药房, 2017,28(35):5020-5023. [3] Atal SS,Atal S.Ulinastatin—a newer potential therapeutic option for multiple organ dysfunction syndrome[J].J Basic Clin Physiol Pharmacol, 2015, 27(2):91-99. [4] Massoudy P, Zahler S, Becker BF, et al.Evidence for inflam-matory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass[J].Chest, 2001, 119(1):31-36. [5] Inoue K, Takano H, Shimade A, et a1.Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide[J].Mol Pharmacol, 2005, 67 (3):673-680 [6] Onorati F, Rubino AS, Nucera S, et al.Off-pump coronary artery bypass surgery versus standard linear or pulsatile cardiopulmonary bypass:endothelial activation and inflammatory response.[J].Eur J Cardiothorac Surg, 2010, 37(4):897-904. [7] Alam SR, Stirrat C, Spath N, et al.Myocardial inflammation,injury and infarction during on-pump coronary artery bypass graft surgery[J].J Cardiothorac Surg, 2017, 12(1):115-124.